(rac)-4-(5-(1-tert-butyl-4,5,6,7-tetrahydro-1H-benzo[d][1,2,3]triazol-5-yl)-1,2,4-oxadiazol-3-yl)morpholine

ID: ALA3735297

PubChem CID: 127034896

Max Phase: Preclinical

Molecular Formula: C16H24N6O2

Molecular Weight: 332.41

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC(C)(C)n1nnc2c1CCC(c1nc(N3CCOCC3)no1)C2

Standard InChI:  InChI=1S/C16H24N6O2/c1-16(2,3)22-13-5-4-11(10-12(13)18-20-22)14-17-15(19-24-14)21-6-8-23-9-7-21/h11H,4-10H2,1-3H3

Standard InChI Key:  DOMGNCULJRFQNG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6168   -1.4950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7580   -2.9756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2259   -3.2843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9730   -1.9836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9669   -0.8711    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1783    2.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3521    2.8771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3759    3.5204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5497    3.7691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8393   -4.6540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0560   -5.9274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7704   -7.2464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2699   -7.2872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0549   -6.0091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3406   -4.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  4  1  0
  5  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  1  0
  3 10  1  0
  9 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 12 19  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3735297

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 332.41

Molecular Weight (Monoisotopic): 332.1961

AlogP: 1.53

#Rotatable Bonds: 2

Polar Surface Area: 82.10

Molecular Species: NEUTRAL

HBA: 8

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 0.78

CX LogP: 1.95

CX LogD: 1.95

Aromatic Rings: 2

Heavy Atoms: 24

QED Weighted: 0.82

Np Likeness Score: -1.72

References

1. Ellard JM, Madin A, Philps O, Hopkin M, Henderson S, Birch L, O'Connor D, Arai T, Takase K, Morgan L, Reynolds D, Talma S, Howley E, Powney B, Payne AH, Hall A, Gartlon JE, Dawson LA, Castro L, Atkinson PJ..  (2015)  Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition.,  25  (24): [PMID:26531152] [10.1016/j.bmcl.2015.10.050]

Source

Source(1):

• Scientific Literature